If you liked this article you might like

Biomarin Rare Disease Drug Picks Up European Endorsement Ahead of FDA Action
TherapeuticsMD Hormone Pill Faces Looming FDA Rejection and a Hostile Commercial Market
XBiotech Leaves European Meeting 'Disappointed' Over Colon Cancer Drug Rejection
Tesaro Resorts to PR Razzle Dazzle to Make Ovarian Cancer Drug Appear Cheaply Priced